Chemical Compound
2-Furancarboxamide, N-[(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-;2-Furancarboxamide, N-[(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-
CAS Registry Number
1047634-65-0
Primary record
2-Furancarboxamide, N-[(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-;2-Furancarboxamide, N-[(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-
- 库存
- 8,381 克
- 纯度
- 98.2 %
- CAS
- 1047634-65-0
化合物标识与属性
- CAS
- 1047634-65-0
- PubChem CID
- 51042438
- SMILES
- CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)N[C@@H](CC3=CC(=C(C=C3)F)F)CN)Cl
- Canonical SMILES
- Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl
名称与同义词
- Uprosertib
- uprosertibum
- GSK2141795
- 1047634-65-0
- Uprosertib [USAN]
- Uprosertib [USAN:INN]
- UPROSERTIB [INN]
- ZXM835LQ5E
- Akt inhibitor gsk2141795
- UNII-ZXM835LQ5E
- RefChem:901144
- Uprosertib (USAN/INN)
- UPROSERTIB [WHO-DD]
- Akt inhibitor gsk-2141795
- GSK2141795C
- GSK795
- D01NEC
- GSK-2141795
- Uprosertib (GSK2141795)
- SCHEMBL168584
- Uprosertib, GSK2141795
- C18H16Cl2F2N4O2
- GSK-2141795C
- MFCD28144686
- GTPL7902
- CHEMBL3137336
- SCHEMBL29658441
- AXTAPYRUEKNRBA-JTQLQIEISA-N
- GLXC-90532
- BCP28204
- EX-A1593
- Oral Akt Inhibitor GSK2141795
- BDBM50170284
- NSC778368
- NSC800960
- s7492
- ZINC43197676
- AKOS027323909
- CCG-268992
- CS-3087
- DB11969
- EBC-157250
- NSC-778368
- NSC-800960
- GSK 2141795
- NCGC00390653-01
- AC-30940
- CID:51042438
- DA-58897
- FU103960
- HY-15965
- SID:376229545
- NS00072545
- J3.393.456D
- A15809
- D10674
- F20800
- A930958
- BRD-K38332599-001-01-3
- Q27089099
- (3S,4R)-4-(3-bromophenyl)pyrrolidine-3-carboxylic acid
- C000595149
- N-((S)-1-Amino-3-(3,4-difluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide
- N-[(2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)furan-2-carboxamide
- B0084-462537
- (S)-N-(1-Amino-3-(3,4-difluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide
- 2-Furancarboxamide, N-((1S)-2-amino-1-((3,4-difluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-
- N-((1S)-1-(Aminomethyl)-2-(3,4-difluorophenyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide
- N-[(2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide
- N-{(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-furancarboxamide
- GSK-2141795; GSK2141795; GSK 2141795; GSK795; GSK-795; GSK 795.
- 1047651-74-0
- 1047652-16-3
- 1309371-43-4
- 2-Furancarboxamide, N-[(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-;2-Furancarboxamide, N-[(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-
- 5-AMINO-6-DIMETHYLAMINO-1,3-DIMETHYL-1,3-DIHYDRO-BENZOIMIDAZOL-2-ONE DIHYDROCHLORIDE
- 629-867-9
- N-((1S)-2-amino-1-((3,4-difluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-furancarboxamide
- N-((2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide
- N-((2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)furan-2-carboxamide
- N-[(1S)-1-(Aminomethyl)-2-(3,4-difluorophenyl)ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide
- N-[(1S)-1-(aminomethyl)-2-(3,4-difluorophenyl)ethyl]-5-chloro-4-(4-chloro-2-methyl-pyrazol-3-yl)furan-2-carboxamide
- N-[(2S)-1-Amino-3-(3,4-difluorophenyl)propane-2-yl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazole-5-yl)furan-2-carboxamide